About this market
Emergency Use Authorization for Covid Vaccine: One Hurdle of Many
Who will be the first company to secure an Emergency Use Authorization for a Covid-19 vaccine, and when? This question has circulated in the popular press for a few months and is at the forefront of many Americans’ minds with the upcoming presidential election on November 3rd.
Johnson & Johnson’s coronavirus vaccine trial is paused after ‘adverse event’ in a participant
Johnson & Johnson’s late-stage coronavirus vaccine was paused after a participant reported an “adverse event” about 36 hours earlier, the company’s chief financial officer said Tuesday. The pause will allow the data and safety monitoring board to thoroughly investigate the unexplained illness, CFO Joseph Wolk said in an interview on CNBC’s “Squawk Box.”